Please login to the form below

Not currently logged in
Email:
Password:

Chris Viehbacher

This page shows the latest Chris Viehbacher news and features for those working in and with pharma, biotech and healthcare.

Former Sanofi CEO Viehbacher takes health investment role

Former Sanofi CEO Viehbacher takes health investment role

Willlead the Bertarelli family's $2bn Gurnet Point Capital fund. Chris Viehbacher has added another job to his portfolio of roles since being ousted as Sanofi's chief executive last year. ... Chris has these qualities in abundance.”. Viehbacher

Latest news

  • Sanofi's CEO search ends as Bayer's Brandicourt takes the job Sanofi's CEO search ends as Bayer's Brandicourt takes the job

    But also of note is Brandicourt's French nationality, which could help avoid some of the culture clashes said to have blighted former CEO  Chris Viehbacher's tenure at Sanofi.  . ... As Viehbacher's replacement Brandicourt faces a number of challenges,

  • Rumour mill intensifies around Bayer’s Brandicourt for Sanofi Rumour mill intensifies around Bayer’s Brandicourt for Sanofi

    Sanofi Chairman Serge Weinberg vowed recently that the successor to former CEO Chris Viehbacher - who was fired last October after clashes with the company's board of directors - would be named ... Brandicourt has been linked to the job a number of times

  • Genzyme cuts staff and signs $845m gene therapy pact Genzyme cuts staff and signs $845m gene therapy pact

    The announcements come as Sanofi is still searching for a replacement for former chief executive Chris Viehbacher, who was fired last October after clashes with the company's board of directors. .

  • Leaderless Sanofi sees strong growth Leaderless Sanofi sees strong growth

    Sanofi has been boosted by a healthy growth in revenue for 2014 but its chairman remains under pressure to find a new chief executive after last year's ousting of Chris ... Last year its long-standing CEO Viehbacher was voted out by the firm's board,

  • Genzyme's oral Gaucher drug cleared in Europe Genzyme's oral Gaucher drug cleared in Europe

    Sanofi ex-chief executive Chris Viehbacher said recently that he did not expect Cerdelga to completely cannibalise Cerezyme sales, as the oral drug does not have an indication for use in

More from news
Approximately 2 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    Sanofi’s last non-French CEO, Canadian-German national Chris Viehbacher, parted company with the firm in 2014, reportedly over his decision to relocate to Boston.

  • Creating stability with medicines framework Creating stability with medicines framework

    The framework agreement was developed on the basis of a conversation between then EFPIA president, Chris Viehbacher, and the Prime Minister of Lithuania, within the context of the Lithuanian Presidency of

  • Going the distance Going the distance

    This comes after its former CEO, Chris Viehbacher, last year conceded the company had been rather 'light' on launches.

  • Pharma deals during October 2014 Pharma deals during October 2014

    So watch this space. The need to keep the shareholders happy is paramount as evidenced by the rather unexpected dispatch of Sanofi's CEO Chris Viehbacher following concerns over the impact

  • Interview: Laure Thibaud, Sanofi Interview: Laure Thibaud, Sanofi

    Chris Viehbacher has said too that he was very happy that Genzyme actually influenced Sanofi's culture in that respect.”. ... It also followed a series of changes at the company following Viehbacher's 2008 appointment as chief executive, such as the

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    For example, the recently departed CEO of Sanofi, Chris Viehbacher, remarked in 2012, “Places like Colombia have become extremely interesting in terms of growth”.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics